Stockscreener 앱 받기
2.29
2.97%
-0.07
시간 외 거래:
2.29
전일 마감가:
$2.36
열려 있는:
$2.35
하루 거래량:
92,675
Relative Volume:
0.30
시가총액:
$18.30M
수익:
$2.90M
순이익/손실:
$87.91M
주가수익비율:
0.1467
EPS:
15.6103
순현금흐름:
$-26.93M
1주 성능:
-15.19%
1개월 성능:
+5.53%
6개월 성능:
+54.73%
1년 성능:
-54.60%
1일 변동 폭
$2.27
$2.3999
1주일 범위
$2.02
$2.76
52주 변동 폭
$0.97
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
명칭
Traws Pharma Inc
전화
267-759-3680
주소
12 PENNS TRAIL, NEWTOWN
TRAW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
2.29 | 18.86M | 2.90M | 87.91M | -26.93M | 15.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-03 | 개시 | H.C. Wainwright | Buy |
| 2022-03-01 | 개시 | Ladenburg Thalmann | Buy |
| 2021-05-18 | 개시 | Guggenheim | Buy |
| 2018-03-01 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-17 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-09 | 개시 | H.C. Wainwright | Buy |
| 2017-04-27 | 개시 | Laidlaw | Buy |
| 2015-07-01 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | 개시 | H.C. Wainwright | Buy |
모두보기
Traws Pharma Inc 주식(TRAW)의 최신 뉴스
Traws Pharma (NASDAQ:TRAW) Upgraded at Zacks Research - Defense World
HC Wainwright Estimates Traws Pharma FY2025 Earnings - Defense World
Traws Pharma (NASDAQ:TRAW) Cut to “Sell” at Wall Street Zen - Defense World
HC Wainwright Estimates Traws Pharma Q4 Earnings - Defense World
Can Traws Pharma Inc. (0T20) stock sustain institutional flowsTrade Risk Assessment & Consistent Growth Equity Picks - Newser
What earnings margins imply for Traws Pharma Inc. (0T20) stock2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
HC Wainwright Begins Coverage on Traws Pharma (NASDAQ:TRAW) - Defense World
Is Traws Pharma Inc. stock trading near support levelsTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
How Traws Pharma Inc. (0T20) stock behaves under inflation pressureJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser
Will Traws Pharma Inc. (0T20) stock benefit from sector leadership2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Why ETFs are accumulating Traws Pharma Inc. (0T20) stockQuarterly Earnings Report & Entry and Exit Point Strategies - Newser
Is Traws Pharma Inc. (0T20) stock positioned for secular growthWeekly Loss Report & Weekly High Return Stock Forecasts - Newser
Is Traws Pharma Inc. (0T20) stock prepared for digital transition2025 Market WrapUp & Stepwise Trade Signal Guides - Newser
HC Wainwright & Co. Initiates Coverage of Traws Pharma (TRAW) with Buy Recommendation - Nasdaq
This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Traws Pharma (TRAW) Receives Buy Rating from HC Wainwright & Co. - GuruFocus
Is Traws Pharma Inc. stock a safe buy before earnings2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
Will Traws Pharma Inc. (0T20) stock recover faster than industry - Newser
Traws Pharma shareholders approve incentive plan changes and elect directors - Investing.com Nigeria
Traws Pharma Begins Phase 2 Trial of Ritonavir-Free COVID-19 Treatment Ratutrelvir - MSN
[Form 4] Traws Pharma, Inc. Insider Trading Activity - Stock Titan
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Traws Pharma’s TRX-100 Study: A Potential Game-Changer in Pharmacokinetics - MSN
Is Traws Pharma Inc. stock a defensive play in 2025Rate Cut & Consistent Return Strategy Ideas - newser.com
Is Traws Pharma Inc. (0T20) stock testing key supportCEO Change & Safe Capital Investment Plans - newser.com
Why Traws Pharma Inc. (0T20) stock could be next leaderMarket Activity Summary & Fast Moving Market Watchlists - newser.com
How Traws Pharma Inc. stock reacts to inflationary pressuresLong Setup & Consistent Growth Stock Picks - newser.com
Is Traws Pharma Inc. stock a contrarian buyCEO Change & Consistent Profit Trade Alerts - newser.com
Is a relief rally coming for Traws Pharma Inc. holdersRate Hike & Safe Capital Growth Trade Ideas - newser.com
Traws Pharma, Inc. (TRAW) stock price, news, quote and history - Yahoo Finance UK
Traws Pharma Pushes Ahead on COVID and Flu Antivirals as Costs Fall and Pipeline Advances - MyChesCo
How Traws Pharma Inc. (0T20) stock trades pre earningsWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Price action breakdown for Traws Pharma Inc.2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
Traws Pharma Inc (TRAW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.44%
0.91%
자본화:
|
볼륨(24시간):